World's shortest bear market or world's greatest fools?

Wall Street entered into a new bull market and that'll only add more fuel to the debate on whether the bounce is s false dawn.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Wall Street entered into a new bull market and that'll only add more fuel to the debate on whether the bounce is s false dawn.

A bull market is a bounce of 20% or more from a trough and the S&P 500 achieved that feat after it recorded its best trading week since 1974!

But the bears are warning investors not to be suckered into a false sense of security. Global markets, including the S&P/ASX 200 Index (Index:^AXJO), are on the verge of a second collapse, so they say. Are they right?

History favours the bears

History is on the side of the pessimists. No bear market in history has ever been this short and this one is running for less than two months.

Further, bear markets are punctuated with false rallies, more affectionately termed "dead cat bounce". The doomsayers also believe a deep recession is on the cards due to a protracted shutdown of the global economy to contain the coronavirus pandemic.

In fact, the dreaded "D" word (for depression) is being increasingly used by some economists who are warning that this sharp downturn will be the most painful in modern history.

The gloomy prediction certainly doesn't gel with the not-very-deep and shortest ever bear market.

This time is different… really

Trying to pick the bottom of the market may be a mug's game, but I'm a glass-half-full kind of guy – in this case anyway.

The difference in this bear market is the unprecedented level of fiscal and monetary stimulus that's being pumped through the financial system.

The US Federal Reserve upped the ante on Thursday when it said it would spend up to US$2.3 trillion ($3.6 trillion) to provide loans to local governments, businesses and households.

Second game changer

My jaw dropped at the news and that says a lot as few things surprise me these days. Investors can't underestimate the significance of the Fed's move.

The world's most powerful central bankers have never moved so far up the risk curve and it's the second game changer I've seen during this crisis (the first being the $130 billion JobKeeper program).

The market adage "don't bet against the Fed" was coined for a reason. The bears will run out of capital long before the Fed does.

Thank goodness for the GFC

The other key difference in this bear market compared to others is the speed which governments and central bankers have been galvanised into action.

We can thank the GFC for this. Even as the global economy was sinking into a hole during the GFC, central bankers (especially those in Europe) were dragging their feet to take action.

It was like debating whether to get into the life boat of the Titanic because you were worried about getting seasick!

This time round, the Feb is pulling out its bazooka, firing first and asking questions later. This will create plenty of problems for us down the track, but hey, that's a problem for tomorrow.

The hidden cost to control COVID-19

Another thing that's making me more of an optimist is my prediction that the restrictive measures put in place to flatten the virus curve will be lifted sooner than what government reps are telling us.

That sounds like an irresponsibly bullish forecast – but consider this: the focus thus far is on how many people are losing their life from COVID-19. Every life lost is a tragedy, but an extended lockdown could claim more lives.

Experts predict that as many as 580 million people around the world will be pushed into poverty because of coronavirus.

Poverty cost lives, even in rich countries. A study undertaken in 2011 estimated that 4.5% of deaths in the US, or roughly 900,000 deceased, are caused by poverty.

There are also reports that the lockdown is impacting on other important medical research, such as the development of anti-cancer treatments.

If the lockdown that's strangling our economy were to last much longer, more of us will be asking whether the hidden costs to control COVID-19 is worth the reward.

Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. Connect with him on Twitter @brenlau.

The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Coronavirus News

Man with his hand on his face looking at a falling share price chart on a tablet.
Share Market News

ASX 200 stocks dive 2.4% in worst trading day since Ukraine crisis hit

It's not a good start to the week for the market.

Read more »

A woman looks nervous and uncertain holding a hand to her chin while looking at a paper cut out of a plane that she's holding in her other hand. representing the falling Air New Zealand share price today
Travel Shares

Borders just reopened so why is the Flight Centre (ASX:FLT) share price falling today?

Experts believe it may take several years for tourism levels to rebound to pre-pandemic numbers.

Read more »

A worker in hi vis gear holds his hand up saying no.
Coronavirus News

Own BHP (ASX:BHP) shares? Here's how the ASX 200 miner is battling COVID

Mining unions have not generally supported mandatory vaccinations.

Read more »

Female worker sitting desk with head in hand and looking fed up
Coronavirus News

Here's what Rio Tinto (ASX:RIO) boss says is 'causing some challenges' right now

The Omicron variant is spreading in Western Australia.

Read more »

A man wearing a mask punches the air with joy after getting a negative COVID result on a rapid antigen test.
Coronavirus News

Why are ASX COVID test shares climbing today?

COVID-19 tests are in focus again today.

Read more »

a girl stands in an apple orchard holding two red apples in raised arms with a happy, celebratory look on her face with a large smile and a pretty country background to the picture.
Economy

CBA reveals the Australian economy's leading state amid COVID surge

The states and territories have all been impacted by the pandemic.

Read more »

Rapid Antigen Test taking place.
Share Market News

Why is Ellume hitting headlines today?

Brisbane-based diagnostics developer Ellume is back in the headlines.

Read more »

A woman looks quizzical as she looks at a graph of the share market.
Share Market News

Inghams (ASX:ING) share price sinks as Omicron bites

Inghams shares are down as COVID hurts its operations.

Read more »